Table 2 Prognostic independence of relevant clinical and histological parameters in the analyzed the Cancer Genome Atlas (TCGA) patient cohorts
| Â | HR | 95% CI | p-value |
|---|---|---|---|
LUSC (manual TLS) | Â | Â | Â |
STAGE(III+IV) | 1.448147 | [0.9927, 2.113] | 0.0546 |
Manual TLS | 0.989205 | [0.9730, 1.006] | 0.1984 |
LUSC (predicted TLS) | Â | Â | Â |
STAGE(III+IV) | 1.439338 | [0.9876, 2.0977] | 0.0581 |
Predicted TLS | 0.984524 | [0.9696, 0.9997] | 0.0457 |
KIRC (manual TLS) | Â | Â | Â |
STAGE(III+IV) | 3.326768 | [2.1327, 5.189] | 1.16e-07 |
Age | 1.021708 | [1.0025, 1.041] | 0.0267 |
Manual TLS | 1.057970 | [0.9769, 1.146] | 0.1657 |
KIRC (predicted TLS) | Â | Â | Â |
STAGE(III+IV) | 3.404224 | [2.1901, 5.291] | 5.22e-08 |
Age | 1.024197 | [1.0050, 1.044] | 0.0135 |
Predicted TLS | 1.048095 | [0.9659, 1.137] | 0.2596 |